NCT00646308View on ClinicalTrials.gov

Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

TerminatedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

March 31, 2010

Conditions
Growth Hormone DeficiencyPituitary Tumor
Trial Locations (1)

10032

Columbia University Neuroendocrine Unit, New York

Sponsors

Collaborators (2)

EMD Serono
Genentech, Inc.
All Listed Sponsors
collaborator

EMD Serono

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

lead

Columbia University

OTHER

NCT00646308 - Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas | Biotech Hunter | Biotech Hunter